These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 17717150)

  • 1. Tissue-type plasminogen activator and the low-density lipoprotein receptor-related protein mediate cerebral ischemia-induced nuclear factor-kappaB pathway activation.
    Zhang X; Polavarapu R; She H; Mao Z; Yepes M
    Am J Pathol; 2007 Oct; 171(4):1281-90. PubMed ID: 17717150
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The low-density lipoprotein receptor-related protein 1 mediates tissue-type plasminogen activator-induced microglial activation in the ischemic brain.
    Zhang C; An J; Strickland DK; Yepes M
    Am J Pathol; 2009 Feb; 174(2):586-94. PubMed ID: 19147818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microglial low-density lipoprotein receptor-related protein 1 mediates the effect of tissue-type plasminogen activator on matrix metalloproteinase-9 activity in the ischemic brain.
    Zhang C; An J; Haile WB; Echeverry R; Strickland DK; Yepes M
    J Cereb Blood Flow Metab; 2009 Dec; 29(12):1946-54. PubMed ID: 19672275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tissue-type plasminogen activator-mediated shedding of astrocytic low-density lipoprotein receptor-related protein increases the permeability of the neurovascular unit.
    Polavarapu R; Gongora MC; Yi H; Ranganthan S; Lawrence DA; Strickland D; Yepes M
    Blood; 2007 Apr; 109(8):3270-8. PubMed ID: 17170123
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxygen glucose deprivation switches the transport of tPA across the blood-brain barrier from an LRP-dependent to an increased LRP-independent process.
    Benchenane K; Berezowski V; Fernández-Monreal M; Brillault J; Valable S; Dehouck MP; Cecchelli R; Vivien D; Touzani O; Ali C
    Stroke; 2005 May; 36(5):1065-70. PubMed ID: 15817895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tissue-type plasminogen activator induces opening of the blood-brain barrier via the LDL receptor-related protein.
    Yepes M; Sandkvist M; Moore EG; Bugge TH; Strickland DK; Lawrence DA
    J Clin Invest; 2003 Nov; 112(10):1533-40. PubMed ID: 14617754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tissue-type plasminogen activator and the low-density lipoprotein receptor-related protein induce Akt phosphorylation in the ischemic brain.
    An J; Zhang C; Polavarapu R; Zhang X; Zhang X; Yepes M
    Blood; 2008 Oct; 112(7):2787-94. PubMed ID: 18628488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TWEAK-Fn14 pathway inhibition protects the integrity of the neurovascular unit during cerebral ischemia.
    Zhang X; Winkles JA; Gongora MC; Polavarapu R; Michaelson JS; Hahm K; Burkly L; Friedman M; Li XJ; Yepes M
    J Cereb Blood Flow Metab; 2007 Mar; 27(3):534-44. PubMed ID: 16835630
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tissue-type plasminogen activator-binding RNA aptamers inhibiting low-density lipoprotein receptor family-mediated internalisation.
    Bjerregaard N; Bøtkjær KA; Helsen N; Andreasen PA; Dupont DM
    Thromb Haemost; 2015 Jul; 114(1):139-49. PubMed ID: 25855589
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isoflurane Postconditioning Inhibits tPA-Induced Matrix Metalloproteinases Activation After Hypoxic Injury via Low-Density Lipoprotein Receptor-Related Protein and Extracellular Signal-Regulated Kinase Pathway.
    Kim SY; Cheon SY; Kim EJ; Lee JH; Kam EH; Kim JM; Park M; Koo BN
    Neurochem Res; 2017 May; 42(5):1533-1542. PubMed ID: 28303501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ruscogenin reduces cerebral ischemic injury via NF-κB-mediated inflammatory pathway in the mouse model of experimental stroke.
    Guan T; Liu Q; Qian Y; Yang H; Kong J; Kou J; Yu B
    Eur J Pharmacol; 2013 Aug; 714(1-3):303-11. PubMed ID: 23911884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phthalide derivative CD21 attenuates tissue plasminogen activator-induced hemorrhagic transformation in ischemic stroke by enhancing macrophage scavenger receptor 1-mediated DAMP (peroxiredoxin 1) clearance.
    Liu DL; Hong Z; Li JY; Yang YX; Chen C; Du JR
    J Neuroinflammation; 2021 Jun; 18(1):143. PubMed ID: 34162400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tissue-type plasminogen activator induces plasmin-dependent proteolysis of intracellular neuronal nitric oxide synthase.
    Baron A; Hommet Y; Cassé F; Vivien D
    Biol Cell; 2010 Aug; 102(10):539-47. PubMed ID: 20636282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuroserpin protects neurons from ischemia-induced plasmin-mediated cell death independently of tissue-type plasminogen activator inhibition.
    Wu J; Echeverry R; Guzman J; Yepes M
    Am J Pathol; 2010 Nov; 177(5):2576-84. PubMed ID: 20864675
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protective effects of statins involving both eNOS and tPA in focal cerebral ischemia.
    Asahi M; Huang Z; Thomas S; Yoshimura S; Sumii T; Mori T; Qiu J; Amin-Hanjani S; Huang PL; Liao JK; Lo EH; Moskowitz MA
    J Cereb Blood Flow Metab; 2005 Jun; 25(6):722-9. PubMed ID: 15716855
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mindin is a critical mediator of ischemic brain injury in an experimental stroke model.
    Wang L; Lu Y; Zhang X; Zhang Y; Jiang D; Dong X; Deng S; Yang L; Guan Y; Zhu L; Zhou Y; Zhang X; Li H
    Exp Neurol; 2013 Sep; 247():506-16. PubMed ID: 23360804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcription factor nuclear factor-kappa B is activated in neurons after focal cerebral ischemia.
    Stephenson D; Yin T; Smalstig EB; Hsu MA; Panetta J; Little S; Clemens J
    J Cereb Blood Flow Metab; 2000 Mar; 20(3):592-603. PubMed ID: 10724123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuronal activation of NF-kappaB contributes to cell death in cerebral ischemia.
    Zhang W; Potrovita I; Tarabin V; Herrmann O; Beer V; Weih F; Schneider A; Schwaninger M
    J Cereb Blood Flow Metab; 2005 Jan; 25(1):30-40. PubMed ID: 15678110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipoprotein receptor-mediated induction of matrix metalloproteinase by tissue plasminogen activator.
    Wang X; Lee SR; Arai K; Lee SR; Tsuji K; Rebeck GW; Lo EH
    Nat Med; 2003 Oct; 9(10):1313-7. PubMed ID: 12960961
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aggravation of focal cerebral ischemia by tissue plasminogen activator is reversed by 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor but does not depend on endothelial NO synthase.
    Kilic E; Kilic U; Matter CM; Lüscher TF; Bassetti CL; Hermann DM
    Stroke; 2005 Feb; 36(2):332-6. PubMed ID: 15625301
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.